BNTXN:BMV
BioNTech SE - ADR
MX$1,645.60
0.00%
(0.00) 1D
Sep 10, 7:49:33 AM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BNTXN...
Mkt. cap
24.34B
Avg. vol.
25.00
Volume
0.00
52-wk high
MX$1,999.00
52-wk low
MX$1,456.73
No. of employees
8K
Mkt. cap
24.34B
Avg. vol.
25.00
Volume
0.00
52-wk high
MX$1,999.00
52-wk low
MX$1,456.73
No. of employees
8K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
BioNTech to close three German sites. BioNTech stock costs EUR 86.10 in weekend trading
AD HOC NEWS
·
17 hours ago
BioNTech's Founders Sell Shares and Face Fresh Patent Suits as German Plants Wind Down
AD HOC NEWS
·
1 day ago
Morgan Stanley sets USD 115 target for BioNTech stock
AD HOC NEWS
·
2 days ago
BioNTech stock after-hours at EUR 87.00: plus 0.29 percent
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR